go-v.orgcodex
Menu
Page tools

codex · Chemistry

Rolapitant

Diagram for Rolapitant
Rolapitant (INN, trade name Varubi və-ROO-bee in the US and Varuby in the European Union) is a drug originally developed by Schering-Plough and licensed for clinical development by Tesaro, which acts as a selective NK1 receptor antagonist (antagonist for the NK1 receptor). It has been approved as a · image: Wikimedia Commons

Rolapitant (INN, trade name Varubi və-ROO-bee in the US and Varuby in the European Union) is a drug originally developed by Schering-Plough and licensed for clinical development by Tesaro, which acts as a selective NK1 receptor antagonist (antagonist for the NK1 receptor). It has been approved as a medication for the treatment of chemotherapy-induced nausea and vomiting (CINV) after clinical trials showed it to have similar or improved efficacy and some improvement in safety over existing drugs for this application.

Wikipedia contributors, "Rolapitant", Wikipedia, revision 1384959399, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex